Leslie TF, Frankenfeld CL , Menon N. 2022. Disparities in colorectal cancer time-to-treatment and survival time associated with racial and economic residential segregation surrounding the diagnostic hospital, Georgia 2010–2015. Cancer Epidemiol 81(Dec):102267; doi: 10.1016/j.canep.2022.102267 . PMID: 36166941.
View Abstract
Publication: Manuscripts
Suh M , Cloud M, Balasubramanian A, Movva N , Fryzek J, Cohen S. 2022. A systematic literature review (SLR) of MTAP deletions in multiple solid and hematologic cancers. PROSPERO 2022 CRD42022354037 .
View Abstract
Publication: Protocol Registrations
Schenfeld J, Gong T, Henry D, Kelsh M , Gawade P, Peng Y, Bradbury BD, Li S. 2022. Patterns of primary prophylactic granulocyte colony-stimulating factor use in older Medicare patients with cancer receiving myelosuppressive chemotherapy. Support Care Cancer 30(7):6327–6338; doi: 10.1007/s00520-022-06967-x . PMID: 35482126.
View Abstract
Publication: Manuscripts
Gillezeau C, Movva N , van Gerwen M, Rabon-Stith K, Shire N, Brohawn PZ, Taioli E, Fryzek J. 2022. Interferon gamma expression and mortality in unselected cohorts of urothelial bladder cancer patients. PLoS One 17(8):e0271339; doi: 10.1371/journal.pone.0271339 . PMID: 36040901.
View Abstract
Publication: Manuscripts
Bylsma L , Fryzek J, Movva N , Frankenfeld C , Hooda N , Pundole X, et al. 2022. Systematic literature review of the prevalence and prognostic value of delta-like ligand 3 protein expression in small cell lung cancer. PROSPERO 2022 CRD42022351119
View Abstract
Publication: Protocol Registrations
Danese MD, Schenfeld J, Shaw J, Gawade P, Balasubramanian A, Kelsh M , et al. 2022. Association between granulocyte colony-stimulating factor (G-CSF) use and myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) among elderly patients with breast, lung, or prostate cancer. Adv Ther 39(6):2778–2795; doi:10.1007/s12325-022-02141-1 . PMID: 35430673.
View Abstract
Publication: Manuscripts
Anneberg M, Svane HML, Fryzek J, Nicholson G, White JB, Edris B, Smith LM, Hooda N , et al. 2022. The epidemiology of desmoid tumors in Denmark. Cancer Epidemiol 77(April):102114; doi: 10.1016/j.canep.2022.102114 . PMID: 35121405.
View Abstract
Publication: Manuscripts
2021
Hooda N , Svane HML, Fryzek J, Nicoholson G, White JB, Edris B, Smith LM, Petersen MM, et al. The epidemiology of desmoid tumors in Denmark. Poster presented at the Connective Tissue Oncology Society Annual Meeting, November 2021.
Publication: Abstracts and Presentations
Frankenfeld CL , Leslie TF, Menon NM. 2021. Longer time-to-treatment but better survival for colorectal cancer patients presumptively not diagnosed in a hospital. Cancer Causes Control 32(10):1185–1191; doi: 10.1007/s10552-021-01464-8 . PMID: 34160709.
View Abstract
Publication: Manuscripts
Hackshaw A, Cohen SS, Reichert H , Kansal AR, Chung KC, Ofman JJ. 2021. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. Brit J Cancer 125(10):1432-1442; doi: 10.1038/s41416-021-01498-4 . PMID: 34426664.
View Abstract
A Division of